Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Mileshkin

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Thorax|May 4, 2019
Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trialLara Edbrooke, Sanchia Aranda, Catherine L Granger, et al.
Cancers|June 24, 2022
Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical PracticeLinda Mileshkin, Tilmann Bochtler, Gemma Gatta, et al.
Journal of Medical Imaging and Radiation Oncology|April 10, 2016
Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trialMichael G Jameson, Jo McNamara, Michael Bailey, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2011
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancerDavid S Binns, Andrea Pirzkall, Wei Yu, et al.
The Oncologist|January 25, 2014
Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imagingBrett Hughes, Linda Mileshkin, Peter Townley, et al.
Gynecologic Oncology|September 5, 2022
Women with gynaecological cancer awaiting radiotherapy: Self-reported wellbeing, general psychological distress, symptom distress, sexual function, and supportive care needsKarla Gough, Rebecca Jane Bergin, Allison Drosdowsky, et al.
BMC Cancer|October 1, 2017
Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer - protocol for a phase II randomised controlled trialLara Edbrooke, Sanchia Aranda, Catherine L Granger, et al.
Gynecologic Oncology|August 17, 2019
OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivorsKate Webber, Elisa Carolus, Linda Mileshkin, et al.
BMJ Open|July 31, 2023
Evaluation of Managing Cancer and Living Meaningfully (CALM) in people with advanced non-small cell lung cancer treated with immunotherapies or targeted therapies: protocol for a single-arm, mixed-methods pilot studyFiona Anne Lynch, Gary Rodin, Michael Jefford, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Thorax|May 4, 2019
Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trialLara Edbrooke, Sanchia Aranda, Catherine L Granger, et al.
Cancers|June 24, 2022
Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical PracticeLinda Mileshkin, Tilmann Bochtler, Gemma Gatta, et al.
Journal of Medical Imaging and Radiation Oncology|April 10, 2016
Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trialMichael G Jameson, Jo McNamara, Michael Bailey, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2011
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancerDavid S Binns, Andrea Pirzkall, Wei Yu, et al.
The Oncologist|January 25, 2014
Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imagingBrett Hughes, Linda Mileshkin, Peter Townley, et al.
Gynecologic Oncology|September 5, 2022
Women with gynaecological cancer awaiting radiotherapy: Self-reported wellbeing, general psychological distress, symptom distress, sexual function, and supportive care needsKarla Gough, Rebecca Jane Bergin, Allison Drosdowsky, et al.
BMC Cancer|October 1, 2017
Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer - protocol for a phase II randomised controlled trialLara Edbrooke, Sanchia Aranda, Catherine L Granger, et al.
Gynecologic Oncology|August 17, 2019
OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivorsKate Webber, Elisa Carolus, Linda Mileshkin, et al.
BMJ Open|July 31, 2023
Evaluation of Managing Cancer and Living Meaningfully (CALM) in people with advanced non-small cell lung cancer treated with immunotherapies or targeted therapies: protocol for a single-arm, mixed-methods pilot studyFiona Anne Lynch, Gary Rodin, Michael Jefford, et al.
Pageof 18